Director/PDMR Shareholding

RNS Number : 5629I
GlaxoSmithKline PLC
03 July 2013
 



 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 2 July 2013 of an increase in their notional interests in Ordinary Shares and American Depositary Shares (ADSs). In respect of the 2011 and 2012 Plan awards, this reflects a reconciliation of notional dividends following a change in Plan administration such that the originally intended number of notional dividends will accrue over the course of the relevant vesting period. The notional dividends were re-invested on 28 June 2013 at an average price of 1404.56 pence per Ordinary Share and $44.5889 per ADS in respect of 2011 Plan awards and at an average price of 1448.10 pence per Ordinary Share and $45.9620 per ADS in respect of 2012 Plan awards.

 

 

Sir Andrew Witty

Acquisition of 1,516 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1,516 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 568 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 568 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

 

Acquisition of 695 ADSs under the personal contribution element of the Plan.




Acquisition of 695 ADSs under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 312 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 312 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 172 ADSs under the personal contribution element of the Plan.




Acquisition of 172 ADSs under the matching element of the Plan (Company contribution).



Mr W C Louv

Acquisition of 94 ADSs under the personal contribution element of the Plan.




Acquisition of 94 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 374 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 374 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms C Thomas

Acquisition of 326 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 326 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 356 ADSs under the personal contribution element of the Plan.




Acquisition of 356 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 675 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 675 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 206 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 206 Ordinary Shares under the matching element of the Plan (Company contribution).

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

3 July 2013

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDXLFBXDFBBBL

Companies

GSK (GSK)
UK 100

Latest directors dealings